
Breakthroughs in the Blood: Leveraging Liquid Biopsy to Improve Cancer Care
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Cancer is the second leading cause of death globally, accounting for nearly 10 million deaths each year. Late-stage diagnosis is a major contributor of cancer-related mortality, as...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...